TREM1 unleashes immunosuppression in glioma: targeting macrophage polarization as a new therapeutic vulnerability - Summary - MDSpire

TREM1 unleashes immunosuppression in glioma: targeting macrophage polarization as a new therapeutic vulnerability

  • By

  • Chao Zhang

  • Da Teng

  • Chao Wang

  • Runsheng Feng

  • Xinqi Huang

  • Ben Hu

  • Yu Wang

  • Ning Lin

  • Cheng Zhang

  • July 3, 2026

  • 0 min

Share

Objective:

To investigate the clinical significance of TREM1 in glioma and its potential role in macrophage polarization.

Approach:
  • Bioinformatics Analysis: Assessment of TREM1 expression patterns and prognostic value in glioma.
  • Cellular Analysis: Utilization of single-cell sequencing, immunohistochemistry, and immunofluorescence to determine TREM1's cellular origin and spatial distribution.
  • Co-culture Model: Evaluation of the impact of TREM1 knockdown on glioma progression and macrophage polarization using CCK-8, Transwell, wound healing assays, western blot, and flow cytometry.
Key Findings:
  • TREM1 expression is upregulated in glioma and associated with higher malignant potential.
  • TREM1 is closely linked to M2-type macrophages and promotes their polarization.
  • Knockdown of TREM1 in macrophages reduces glioma cell proliferation, invasion, and migration.
Interpretation:

Limitations:
  • The study's findings are based on specific patient samples and may not be generalizable.
  • Further research is needed to fully elucidate the mechanisms of TREM1 in glioma.
Conclusion:

The study suggests that targeting TREM1 may enhance the efficacy of immunotherapy for glioma.

Original Source(s)

Related Content